Loading Vancomycin Doses in the Emergency Department

Completed · Not applicable

Conditions studied: Infectious Disease

In brief

In 2008, our ED administered an average of 245 doses of vancomycin per month. Currently there is no consistency in the ED practice in regards to vancomycin dosing. In 2009, the IDSA put forth new recommendations for vancomycin dosing in order to achieve therapeutic levels more rapidly. It has been hypothesized that if therapeutic levels are reached more rapidly then patients will in turn have better clinical outcomes and that the development of resistant organisms will be decreased. Methicillin resistant Staphylococcus aureus (MRSA) has emerged as one of the most deadly pathogens that are currently plaguing our patient population. Vancomycin is one of only a few antibiotics that are effective for treating MRSA. It is imperative that the ED physicians consistently and correctly dose vancomycin in order to give the patients the best chance to fight infection while helping to prevent further resistance in this already highly resistant organism. It is believed this study will reveal that the new dosing recommendations by the IDSA will lead to the achievement of therapeutic levels more rapidly. This information will in turn help to convince ED physicians that a change in current clinical practice is warranted and ultimately lead to better clinically outcomes for the patients.

Key facts

Study ID

NCT01162733

Run by

Christiana Care Health Services

People needed

99

Starts

2010-07-01

Expected to finish

2012-06-01

Last updated by the study team

2014-03-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18 years of age
• Treated in Christiana Emergency Department
• Receiving Vancomycin for an infection or presumed infection
• Being admitted to Christiana Hospital
• Planned continued use of Vancomycin after admission.

You may not qualify if…

• Less than 18 years of age
• Weight greater than 120 kg.
• Concurrent use of aminoglycosides or acyclovir
• Sepsis patients being admitted to ICU with presumed diagnosis of pneumonia
• Patients currently undergoing dialysis
• Pregnant or breast feeding
• No plan to continue Vancomycin after admission.
• Creatinine clearance less than 50ml/min.

Where it is running

• Chrisitana Care Health System-Christiana Hospital — Newark, Delaware, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.